Scher Richard L, Esclamado Ramon M
Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Duke University Health System, Durham, NC 27710, USA.
Semin Radiat Oncol. 2009 Jan;19(1):17-23. doi: 10.1016/j.semradonc.2008.09.004.
The treatment for squamous cell carcinoma (SCC) of the head and neck has advanced considerably with the use of multimodality therapy including radiation, chemotherapy, and surgery. Efforts to achieve greater rates of disease control and survival have been coupled with attempts to reduce acute and chronic toxicity and preserve function. In the setting of advanced-stage disease, these goals have typically been achieved via the use of combined radiation and chemotherapy. Although very effective, (chemo)radiation does not always succeed and may not offer benefits to the patient equal to those achieved with surgical resection and reconstruction. This article discusses the issues involved in the selection of surgical therapy both for the primary treatment of SCC of the head and neck and for salvage of disease persistence or recurrence after chemoradiation.
头颈部鳞状细胞癌(SCC)的治疗随着多模态疗法(包括放疗、化疗和手术)的应用而有了显著进展。在努力实现更高疾病控制率和生存率的同时,人们也在尝试降低急慢性毒性并保留功能。对于晚期疾病,这些目标通常通过联合放疗和化疗来实现。尽管(化疗)放疗非常有效,但并不总是成功,而且对患者的益处可能不如手术切除和重建。本文讨论了头颈部SCC初始治疗以及放化疗后疾病持续或复发挽救治疗中手术治疗选择所涉及的问题。